tert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate

Catalog No. :
ACRGDP782
CAS No. :
1286754-61-7
Molecular Formula :
C11H12BrN3O2
Molecular Weight :
298.14

IUPAC Name:tert-butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate

tert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$139.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate
IUPAC Nametert-butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate
MDL No.MFCD28023868
Molecular FormulaC11H12BrN3O2
Molecular Weight298.14
SMILESO=C(N1N=CC2=C(Br)C=CN=C21)OC(C)(C)C
InChI KeyOVKLQGNUAJSUNP-UHFFFAOYSA-N
Synonym1-Boc-4-bromo-7-aza-1H-indazole;tert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate;1H-Pyrazolo[3,4-b]pyridine-1-carboxylic acid, 4-bromo-, 1,1-dimethylethyl ester;tert-Butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate - [B70320]
CAS No.1286754-61-7
PubChem CID91667296

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRGDP782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBVCD586 route compound structure diagram
    ACBVCD586856859-49-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRGDP782 route product structure diagram
    ACRGDP7821286754-61-7 In Stock
Inquiry

2. ACRGDP782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBVCD586 route compound structure diagram
    ACBVCD586856859-49-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRGDP782 route product structure diagram
    ACRGDP7821286754-61-7 In Stock
Inquiry

Comments (0)